Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor prognosis and limited early detection methods. Circulating tumor cells (CTCs) provide a minimally invasive opportunity to investigate tumor heterogeneity and disease progression, yet their reliable identification among peripheral blood cells remains challenging. In this study, peripheral blood samples were collected from PDAC patients and healthy controls. CTCs were enriched using CytoGen’s Smart Biopsy™ Platform, and the CTC-enriched fractions were analyzed using single-cell RNA sequencing (Cell Ranger 8. 0. 1). Low-quality and doublet cells were filtered (nFeatureRNA 500, percent. mt 10, doublet score 0. 25). Dimensional reduction and clustering (resolution 0. 8) enabled cell type annotation, and copy number variation (CNV) profiles were inferred at the subcluster level (k=5) to assess potential malignant characteristics. Consequently, Distinct cell clusters exhibiting PDAC-associated transcriptional signatures were identified. CNV pattern analyses revealed that certain clusters displayed genomic variability distinct from typical immune and blood cell populations. Comparison with TCGA-PAAD reference data indicated partial resemblance to tumor-like CNV profiles. Moreover, CNV-based stratification tended to distinguish PDAC-derived CTC-enriched clusters from those observed in healthy blood, suggesting potential diagnostic utility. Overall, these integrative single-cell transcriptomic and CNV analyses provide valuable insights into CTC heterogeneity in PDAC and suggest that CNV-informed profiling may enhance the identification of putative CTC populations and facilitate future biomarker development for liquid biopsy-based cancer monitoring. Acknowledgement: This work is supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (RS-2023-00261820). Citation Format: Se-Eun Choi, Jihyun Lee, Hyunjung Kee, Moon Jae Chung, Jungwon Kim, Semin Lee. Single-cell transcriptomic and CNV profiling reveal distinct circulating tumor cell signatures in pancreatic ductal adenocarcinoma abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts) ; 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86 (7 Suppl): Abstract nr 117.
Choi et al. (Fri,) studied this question.